[HTML][HTML] Possible link between SARS-CoV-2 infection and Parkinson's disease: the role of toll-like receptor 4
C Conte - International Journal of Molecular Sciences, 2021 - mdpi.com
Parkinson's disease (PD) is the most common neurodegenerative motor disorder
characterized by selective degeneration of dopaminergic neurons in the substantia nigra …
characterized by selective degeneration of dopaminergic neurons in the substantia nigra …
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
HM Al‐kuraishy, AI Al‐Gareeb… - Journal of …, 2023 - Wiley Online Library
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive
loss of dopaminergic neurons in the substantia nigra. The hallmarks are the presence of …
loss of dopaminergic neurons in the substantia nigra. The hallmarks are the presence of …
[HTML][HTML] The potential role of SARS-COV-2 in the pathogenesis of Parkinson's disease
P Chana-Cuevas, P Salles-Gandara… - Frontiers in …, 2020 - frontiersin.org
Considering their current burden and epidemiological projections, nowadays Parkinson's
disease and the COVID-19 pandemic are two key health problems. There is evidence of the …
disease and the COVID-19 pandemic are two key health problems. There is evidence of the …
[HTML][HTML] Parkinson's Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
S Sinha, S Mittal, R Roy - Journal of movement disorders, 2021 - ncbi.nlm.nih.gov
There is an extensive debate on the neurological consequences of 2019 novel coronavirus
disease (COVID-19) and its impact on Parkinson's disease (PD) patients, which seems to …
disease (COVID-19) and its impact on Parkinson's disease (PD) patients, which seems to …
[HTML][HTML] SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms
M Pennisi, G Lanza, L Falzone, F Fisicaro… - International Journal of …, 2020 - mdpi.com
Increasing evidence suggests that Severe Acute Respiratory Syndrome-coronavirus-2
(SARS-CoV-2) can also invade the central nervous system (CNS). However, findings …
(SARS-CoV-2) can also invade the central nervous system (CNS). However, findings …
[HTML][HTML] Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Dopamine (DA) is a key neurotransmitter in the basal ganglia, implicated in the control of
movement and motivation. Alteration of DA levels is central in Parkinson's disease (PD), a …
movement and motivation. Alteration of DA levels is central in Parkinson's disease (PD), a …
[HTML][HTML] Neurological manifestation of SARS-CoV-2 induced inflammation and possible therapeutic strategies against COVID-19
There are regular reports of extrapulmonary infections and manifestations related to the
ongoing COVID-19 pandemic. Coronaviruses are potentially neurotropic, which renders …
ongoing COVID-19 pandemic. Coronaviruses are potentially neurotropic, which renders …
[HTML][HTML] The intersection of Parkinson's disease, viral infections, and COVID-19
B Rosen, A Kurtishi, GR Vazquez-Jimenez… - Molecular …, 2021 - Springer
Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the
causative agent of human COVID-19, not only causes flu-like symptoms and gut microbiome …
causative agent of human COVID-19, not only causes flu-like symptoms and gut microbiome …
[HTML][HTML] Complications and Pathophysiology of COVID-19 in the Nervous System
H Yu, T Sun, J Feng - Frontiers in neurology, 2020 - frontiersin.org
The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global public health threat. Majority …
syndrome coronavirus 2 (SARS-CoV-2), has become a global public health threat. Majority …
[HTML][HTML] SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now
I Boura, MA Qamar, F Daddoveri, V Leta… - Biomedicines, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has been discussed in the context of Parkinson's disease (PD) …
disease 2019 (COVID-19), has been discussed in the context of Parkinson's disease (PD) …